RxDoctor Payments Data

Marguerite Salam Host, MD

Anatomic Pathology & Clinical Pathology · Scranton, PANPI 1619917895

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $389,163 of the $389,843 with a category attached, or 99.8%. 8 manufacturers reported payments, led by Kedplasma LLC at 44.2% of the total. Reporting peaked in 2022 at $99,361 and has fallen 69.8% since, to $30,000 in 2025. Among anatomic pathology & clinical pathology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$389,843in general payments, 2019–2025

Across 292 payments — averaging $1335.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kedplasma LLC$173K
  • CSL Behring$160K
  • CSL Plasma Inc.$57K
  • Seagen Inc.$469
  • Myriad Genetic Laboratories, Inc.$102
  • Stemline Therapeutics Inc.$65
  • plus $45 from 2 others

What the payments were for

  • Consulting fees$389,163100%
  • Food & beverage$6810%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$389,843 in reported general payments places this provider in the 95th percentile of 357 anatomic pathology & clinical pathology providers in Pennsylvania.

See all anatomic pathology & clinical pathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$192,588
Medicare patients
1,264
Services billed
4,662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Scranton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →